Barbara Lopez Kunz serves as Executive at Aptevo Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Barbara Lopez Kunz has executed 6 insider transactions totaling $8.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 2, 2024 involved exercising options for 81 shares valued at $0.
Barbara Lopez Kunz currently holds 198 shares of Aptevo Therapeutics Inc. (APVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Lopez Kunz has been a net buyer of APVO stock. They have purchased $8.5K and sold $0 worth of shares.
Barbara Lopez Kunz's most recent insider trade was on Jun 2, 2024, when they sold 81 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 9, 2023 | APVO | $0 | Option Exercise | 3,571 | $N/A | Discretionary |
| Jun 1, 2023 | APVO | $0 | Option Exercise | 297 | $N/A | Discretionary |
| Jun 1, 2022 | APVO | $0 | Option Exercise | 298 | $N/A | Discretionary |
| Jun 10, 2019 | APVO | $8.5K | Purchase | 10,000 | $0.85 | Discretionary |